Navigation Links
Bone Therapy May Not Always Need Monitoring
Date:6/24/2009

In older women, annual measurements are unnecessary, study finds

WEDNESDAY, June 24 (HealthDay News) -- Monitoring bone density in older women after they've started taking drugs to prevent osteoporosis is unnecessary and could be potentially misleading, researchers say.

In the study, Australian researchers analyzed data from a large randomized trial that compared the effects of the drug alendronate (a widely used bisphosphonate) in more than 6,000 postmenopausal women with low bone mineral density, which is a risk factor for fractures.

The women's bone density was measured at the start of the study and again one, two and three years later. After three years of treatment, 97.5 percent of the women who took the drug showed at least a modest increase in bone density, and there was little variation in the treatment effect between individuals, the researchers found.

The findings, which appear online June 24 in BMJ, suggest that monitoring a person's response during the first three years of the treatment is unnecessary and, because of the potential to mislead, should not be done, concluded the researchers, from the School of Public Health at the University of Sydney.

The results support the case against routine monitoring during the early years of treatment, according to an accompanying editorial by Juliet Compston, professor of bone medicine at the University of Cambridge, in England. She said that when changes in bone mineral density are used to monitor treatment, people may be given inappropriate advice.

"Routine monitoring of bone mineral density during the first few years of antiresorptive treatment cannot be justified because it may mislead patients, lead to inappropriate management decisions and waste scarce health care resources," she concluded.

More information

The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases offers tips on '/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Dynatronics Begins Shipping New V-Force Vibration Therapy Units
2. Biomarkers predict brain tumors response to therapy
3. Determining Who Will Respond to Brain Tumor Therapy
4. Promising Therapy for Prostate Cancer
5. AthletiCo Opens 52nd Physical Therapy Center in South Elgin
6. Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain
7. US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease
9. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
10. Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital
11. Spinal Decompression Therapy Offers Hope for Back Pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bone Therapy May Not Always Need Monitoring 
(Date:9/4/2015)... ... September 04, 2015 , ... With TransCel from Pixel ... all within Final Cut Pro X. With TransCel users have full control over camera ... background color, speed method, frame color, inner color, text, and more. With TransCel the ...
(Date:9/4/2015)... ... 2015 , ... The Schmidt National Law Group filed an Essure® lawsuit against ... National Law Group, a leading firm in mass-tort litigation, has filed a lawsuit in ... Inc., and other Bayer affiliates for injuries alleged to have been caused by her ...
(Date:9/4/2015)... ... 04, 2015 , ... IVF New England, one of the largest and most ... Hour" in Manchester for women who wish to learn more about their fertility and ... and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This hip, ...
(Date:9/4/2015)... Marietta, GA (PRWEB) , ... September 04, 2015 , ... ... team is in desperate need of new apparel. In an effort to assist the ... around Marietta, has launched a charity drive to raise funds for the new uniforms. ...
(Date:9/4/2015)... ... September 04, 2015 , ... A ... Compassion Project. Core Compassion Project is a non-profit organization dedicated to offering ... side effects of cancer treatments and recover their mobility, strength, and range of ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2
... Cosmetic Surgery in San Diego is the first in the US to ... ... San Diego, California (PRWEB) May 6, 2009 -- A gentler form of ... at his New Image Cosmetic Surgery center in San Diego, CA. This ...
... Executives, annual conference in San Antonio, Texas, the newest recipient of ... L. Bertram, RN, MBA, NEA-BC, FAAN, vice president and chief nursing ... , ... Lenexa, Kan. (PRWEB) May 6, 2009 -- At ...
... (Nasdaq: MTXX ), an over-the-counter healthcare company that ... to Get Better(R)," announced today that its financial results for ... will be released after the market closes on Monday, May ... following morning on Tuesday, May 12, 2009 at 11:00 AM ...
... Lasik Medspas Offers Customers Ultimate Advantage With Economy-Friendly ... circumstances, the current economy can open doors for ... financial climate. A prime example of such prospects ... medspa center, Viso Lasik Medspas, presents its clientele ...
... NEWPORT BEACH, Calif., May 5 Nationwide Health Properties, Inc. (NYSE: ... declared a $0.44 per share dividend on our common stock that ... on May 15, 2009. , , In addition, ... our Series B cumulative convertible preferred stock that will be paid ...
... Derma Sciences (OTC ... care products, today announced that it intended to voluntarily delist ... Stock Exchange and that it would file Form 25 with ... 2009 to effect this delisting.Ed Quilty, CEO of Derma Sciences, ...
Cached Medicine News:Health News:Body-Jet Liposuction First Introduced in the United States 2Health News:Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants 2Health News:Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants 3Health News:Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2009 Financial Results 2Health News:Financial Advantage In The Current Economy: Lasik Eye Vision Correction Allows Patients To Approach The Future With Clear Vision And Confidence 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange 2
(Date:9/3/2015)... LONDON , Sept. 3, 2015 ... ophthalmic devices market? Which areas are going to grow ... you potential revenues to 2025, assessing data, trends, opportunities ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
(Date:9/3/2015)... 2015 With a population of more than ... therefore also its single largest potential market for goods ... led all major world economies in the average rate ... government health expenditures. As an in vitro diagnostics (IVD) ... the United States, western European countries, and Japan. China ...
(Date:9/3/2015)... YORK , Sept. 3, 2015 ... glucose device is a home-based electronic device. It ... that transmits information about glucose levels through radiowaves ... is displayed. The regular usage of self-monitoring blood ... prompt an individual to undergo proper diabetes treatment. ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... 29, 2012 The Board of Directors of ... SUNPHARMA, BSE: 524715) met today and announced appointment of Mr Israel ... is the former President and CEO of Teva Pharmaceutical Industries ... and is widely credited with Teva,s emergence as a global ...
... SAN DIEGO, May 29, 2012  Marshall Edwards, Inc. (Nasdaq: ... development of novel therapeutics targeting cancer metabolism, announced today that ... Phase I clinical trial of ME-344, the Company,s lead mitochondrial ... dose escalation trial is expected to enroll up to 24 ...
Cached Medicine Technology:Israel Makov Appointed Chairman of Sun Pharma Board 2Israel Makov Appointed Chairman of Sun Pharma Board 3Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 2Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 3Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 4
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
... Eliminate aerosol contamination, which ... in PCR. Hydrophobic, nonwicking ... air can pass through ... in contrast to tips ...
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
Medicine Products: